Home > Quotes > PRXL
PRXL

PAREXEL International Corporation Common Stock Quote & Summary Data

$61.1
*  
0.52
0.86%
Get PRXL Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading PRXL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

PAREXEL International Corporation Common Stock Intraday Chart




Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 61.68 $ 76.17
Low $ 59.68 $ 56

The current last sale of $61.10 is 9.11% Higher thanthe 52 week low.

P/E Ratio

ETFs with PRXL as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
0.81% iShares Morningstar Small-Cap Growth ETF (JKK) -5.35 (-3.90%)
0.8% PowerShares Russell 2000 Pure Growth Portfolio (PXSG) -2.21 (-8.59%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

PAREXEL International Corporation ("PAREXEL," "the Company," or "we") is a leading biopharmaceutical services company, providing a broad range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. Our primary objective is to provide quality solutions for managing the biopharmaceutical product lifecycle with the goal of reducing the time, risk, and cost associated with the development and commercialization of new therapies. Since our incorporation in 1983, we have developed significant expertise in processes and technologies supporting this strategy.  ... More ...  

Risk Grade

Where does PRXL fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?